ArticlePharmacoEconomics - open2017

Differences in Incremental Cost-Effectiveness Ratios for Common Versus Rare Conditions: A Case from Oncology.

Kavisha Jayasundara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.